Biotechnology and Pharmaceuticals

January 15, 2016

Buy ($175)

Companies covered: Gilead Sciences, Inc. (NASDAQ:GILD), Intra-Cellular Therapies Inc. (NASDAQ:ITCI), Cempra, Inc. (NASDAQ:CEMP), Achaogen, Inc. (NASDAQ:AKAO), Wave Life Sciences Ltd (NASDAQ:WVE), Intrexon Corporation (NYSE:XON), Johnson & Johnson (NYSE:JNJ), Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA), ZIOPHARM Oncology Inc (NASDAQ:ZIOP), Fibrocell Science Inc (NASDAQ:FCSC), Synthetic Biologics, Inc (NYSEMKT:SYN), Juno Therapeutics, Inc. (NASDAQ:JUNO), Kite Pharma, Inc. (NASDAQ:KITE), Lightlake Therapeutics (OTCMKTS:LLTP), Cynapsus Therapeutics Inc (NASDAQ:CYNA), Biota Pharmaceuticals, Inc. (NASDAQ:BOTA), Bio-Path Holdings, Inc. (NASDAQ:BPTH)